Consensus on the Practical Use of Amisulpride, an Atypical Antipsychotic, in the Treatment of Schizophrenia

Neuropsychobiology
Y LecrubierJ M Vanelle

Abstract

Clinical expectations in schizophrenia treatment have greatly increased since the introduction of new atypical antipsychotics, but the choice of therapeutic strategy has become more complex and reference guidelines are scarce. This paper summarizes the consensus of a broad range of professionals after long-term commercialization in France of an atypical antipsychotic, amisulpride. Participants were from psychiatric hospitals, private clinics, out-patients settings and research; all were experienced with the drug. Discussions focused on the practical use of amisulpride, as, in addition to the double-blind trials information, it may be useful for psychiatrists of other countries to intuitively understand the therapeutic properties of amisulpride. The topics selected include acute psychotic episodes, short- and long-term follow-up, feasibility of treating the initial phase, the elderly and switching treatments. The French experience emphasizes the central role of amisulpride as a first-line treatment of schizophrenia.

Citations

Jul 20, 2007·Pharmacy World & Science : PWS·Marie Christine BretAnnie Fourier-Réglat
Apr 2, 2004·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·N BergemannA Frick
Feb 19, 2004·European Psychiatry : the Journal of the Association of European Psychiatrists·Mathias ZinkJohannes Thome
May 4, 2005·Progress in Neuro-psychopharmacology & Biological Psychiatry·Simon SurguladzeMichael J Travis
Mar 30, 2005·Clinical Neuropharmacology·Vladimir LernerChanoch Miodownik
Jul 30, 2005·Diabetes, Obesity & Metabolism·A J GoudieJ C G Halford
Oct 3, 2014·Journal of Clinical Psychopharmacology·Shani PridanYoram Barak
May 28, 2010·International Review of Psychiatry·Brendan P Murphy
Nov 26, 2014·Expert Opinion on Investigational Drugs·Ricardo P GarayPierre-Michel Llorca
Aug 31, 2002·Current Medical Research and Opinion·T BurnsK Demyttenaere
Oct 27, 2006·Human Psychopharmacology·Brendan P MurphyPatrick D McGorry
Dec 17, 2008·International Journal of Geriatric Psychiatry·Constantin PsarrosGeorge N Papadimitriou
Feb 1, 2008·Early Intervention in Psychiatry·Brendan P MurphyPatrick D McGorry
Apr 16, 2009·Journal of the American Academy of Nurse Practitioners·Yun-Jung Choi
Sep 18, 2007·Journal of Clinical Psychopharmacology·Niels BergemannJürgen Kopitz
Apr 23, 2010·Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry·Sangita SharmaDipti Dabhi
Dec 6, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Virgilo A SalvoMatthew E Burow
Jan 21, 2006·Cancer Research·Charles E WoodJ Mark Cline

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Clinical Neuropharmacology
Sol JaworowskiHarry Hirsch
Pharmacological Research : the Official Journal of the Italian Pharmacological Society
Nader Perroud, Philippe Huguelet
The Journal of Nervous and Mental Disease
R P Greenberg
© 2021 Meta ULC. All rights reserved